Furuta Milano 4
4 · TAKEDA PHARMACEUTICAL CO LTD · Filed Apr 28, 2026
Research Summary
AI-generated summary of this filing
Takeda (TAK) CFO Furuta Milano Receives RSU Award
What Happened Furuta Milano, Takeda’s Chief Financial Officer, was granted equity awards reported on 2026-04-27. The Form 4 shows an acquisition-type award of 7,800 ordinary-share RSUs and a related 7,814-unit derivative award (total 15,614 units). Both items were reported at $0.00 acquisition price (compensation awards), so no cash was paid by the insider.
Key Details
- Transaction date: April 27, 2026; filing date: April 28, 2026 (filed next day).
- Award details reported: 7,800 RSUs (ordinary shares) + 7,814 Tax Obligation Award units (derivative) = 15,614 total units; reported acquisition price $0.00 (value recorded as compensation, not open-market purchase).
- Shares/units noted in filing: filing also “includes 27,300 RSUs” that are contingent rights to ordinary shares (see vesting schedule below).
- Footnotes: F1 — original RSU grant dated July 1, 2023; Committee determined final award amount on April 27, 2026 based on performance metrics (core revenue, core operating profit, key R&D milestones). F2 — 27,300 RSUs vest on June 1, 2026 (16,200), June 1, 2027 (7,100), and June 1, 2028 (4,000). F3 — Tax Obligation Awards are economic equivalents that convert to cash upon vesting, primarily to cover tax withholding.
- Filing timeliness: appears timely (filed the day after the report date).
Context These are compensation grants tied to performance and vesting schedules, not open-market purchases or sales; they do not by themselves signal a buy or sell preference in the market. The derivative Tax Obligation Award is intended to cover tax withholding at vest and will typically be paid in cash (calculated at the then-current market price) rather than delivered as additional shares.
Insider Transaction Report
- Award
Ordinary Shares
[F1][F2]2026-04-27+7,800→ 57,900 total - Award
Tax Obligation Award
[F3]2026-04-27+7,814→ 16,619 totalFrom: 2026-06-01Exp: 2026-06-01→ Ordinary Shares (7,814 underlying)
Footnotes (3)
- [F1]On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of ordinary shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones. On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above.
- [F2]Includes 27,300 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest on the following schedule: June 1, 2026 (16,200 shares), June 1, 2027 (7,100 shares) and June 1, 2028 (4000 shares).
- [F3]Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.